A Randomized, Double-blind Dose-ranging Study of the Effect of DPP-IV on HbA1c, Other Efficacy Parameters, Pharmacokinetics and Safety in Patients With Type 2 Diabetes (BC20779)
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Carmegliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 02 Dec 2008 Actual completion date changed from July 2008 to March 2008 according to ClinicalTrials.gov.
- 16 Jul 2008 Status changed from in progress to completed as reported by Roche.